Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial

BACKGROUND: Though several neuroprotective agents have been evaluated as potential treatments for acute ischemic stroke, none have demonstrated a definitive treatment efficacy, which remains elusive. HT047 is an herbal extract of Scutellaria baicalensis and Pueraria lobata, both of which have been w...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Sung Hyuk, Song, Jungbin, Kim, Bum Joon, Kim, Hocheol, Chang, Dae-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824685/
https://www.ncbi.nlm.nih.gov/pubmed/31651889
http://dx.doi.org/10.1097/MD.0000000000017655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824685/
https://www.ncbi.nlm.nih.gov/pubmed/31651889
http://dx.doi.org/10.1097/MD.0000000000017655

Ejemplares similares